IGF-1 LR3: structure, nomenclature and handling

The parent is insulin-like growth factor 1, a 70-residue protein of approximately 7,650 daltons. Its fold is stabilised by three disulfide bridges formed among six cysteines, and that internal architecture — rather than the linear sequence alone — is what defines the correctly made molecule. A chain with the right residues in the wrong pairing is a different entity.

LR3 denotes two modifications made to that parent. The first is a substitution: arginine replaces the glutamate at position 3 — the R3 of the name. The second is an extension: a thirteen-residue sequence added at the amino terminus — the L, for long. Together they take the molecule to 83 residues and approximately 9,110 daltons.

Both changes sit outside the disulfide-bonded core, and both address the same property: the parent protein associates tightly with a family of binding proteins in solution, and the substitution and extension reduce that association. It is a protein-protein interaction question, and it is the design rationale the name encodes.

The material is catalogued as IGF-1 LR3, LR3-IGF-1, Long R3 IGF-1 and IGF-1 Long Arg3. All name the same construct. The parent appears as IGF-1, IGF-I and somatomedin C — names belonging to the unmodified 70-residue protein, which is a distinct catalogue entity of different mass.

Because this is a recombinant product, two descriptors matter alongside the name: the expression system and the form supplied. Material of this class is typically produced in bacterial expression, and is generally supplied as a lyophilized solid with an excipient rather than as a bare protein, since proteins at this scale do not survive freeze-drying as reliably as short peptides. What a vial contains is stated on the certificate rather than inferable from the name.

Mass spectrometry confirms the intact molecular mass near 9,110 daltons, distinguishing the modified construct from the unmodified parent by a wide margin. It also reads on the disulfides: forming three bridges releases six hydrogens, so the correctly folded protein is six daltons lighter than the fully reduced chain.

Chromatography and electrophoresis address a question that does not arise for short peptides — aggregation. Size-exclusion chromatography separates monomer from dimer and higher aggregates, and SDS-PAGE gives an orthogonal size read. Reversed-phase HPLC yields the purity figure, with misfolded disulfide isomers as the compound-specific related substance: same mass, different retention, invisible to mass spectrometry alone.

Two further panel items belong to recombinant material specifically. Host cell protein assays quantify residual protein carried over from the expression organism, and endotoxin testing by the LAL method quantifies bacterial lipopolysaccharide. Neither has an equivalent on a synthetic peptide certificate.

HEEZ Research supplies IGF-1 LR3 in a single format: a 1 mg lyophilized vial — the smallest quantity in the catalogue, reflecting that a nine-kilodalton protein is consumed on a different scale from a small peptide.

The material is supplied as a lyophilized powder, which is markedly more stable than the same protein in solution and tolerates ambient shipping temperatures without refrigeration in transit.

At roughly 9,110 daltons this is by far the heaviest molecule in the catalogue, so 1 mg represents a small molar quantity relative to the same mass of a short peptide — a distinction that matters wherever protocols are specified in molar terms.

Reconstitution converts the dried cake into a working solution, and it is a standard laboratory step rather than a product specification. Which solvent is used, and at what final concentration, is determined by the protocol in force at the receiving facility.

What HEEZ specifies is the contents of the vial: lyophilized IGF-1 LR3 in a single 1 mg format, stated on the label and on the batch certificate of analysis. Where a protocol is expressed in molar rather than mass terms, the additional figure it needs is the molecular weight, which the certificate records for the batch supplied.

Two behaviours separate this from peptide handling. Proteins adsorb to glass and plastic surfaces, and with only 1 mg in the vial the proportion lost to container walls is not negligible — low-binding labware is the standard mitigation. And mechanical stress promotes aggregation: a folded protein unfolds at air-liquid interfaces, so vigorous shaking is avoided in a stronger sense here than the general caution applied to short peptides. Gentle swirling, and letting the cake dissolve on its own, is the norm.

Sealed lyophilized material is ambient-stable for the duration of transit, so no cold chain or insulated packaging is required for shipping. On receipt the vial goes to refrigeration and is kept out of direct light.

Reconstituted material is held cold and used within the window the receiving facility's protocols specify. Freeze-thaw cycling is avoided more strictly than for peptides, because each cycle concentrates solutes at the ice interface and drives aggregation — the degradation route that matters most for this molecule.

The disulfide architecture adds its own sensitivity: reducing agents cleave the bridges and alkaline conditions promote disulfide exchange, so a fold that took a manufacturing step to establish can be undone at the bench with no visible change to the solution.

The certificate records what an independent facility measured for one specific batch. Its value lies in being batch-specific, so the first check is that the lot number on the document matches the vial in hand.

The identity section compares observed mass against the theoretical figure for the 83-residue construct near 9,110 daltons — not the 70-residue parent, and not the reduced chain six daltons heavier.

The purity figure is a chromatographic main-peak area, and for a protein the more informative companion is a size-based measurement showing what fraction is monomer rather than aggregate. Where endotoxin or host cell protein figures appear, they describe manufacturing cleanliness rather than the molecule, and they are the items unique to a recombinant certificate.

Content is stated for the protein itself where an excipient is present, since the nominal 1 mg may describe the total solid rather than the protein alone. That is the figure determining how much actual protein a vial holds.